META Group
The MBMC’s META Group conducts knowledge syntheses (e.g., rapid systematic reviews, scoping reviews, living evidence synthesis) in response to decision-maker needs. Previous work has been produced for organisations such as the Public Health Agency of Canada (PHAC), Canada’s SPOR Evidence Alliance (SPOR-EA), and Toronto Public Health.
The META team includes MBMC Co-Director Simon Bacon, PhD, postdoctoral fellow Patrick Boudreau, PhD, PhD student Philipp Kapp, MSc, staff research assistant Laurence Paquet, MSc, as well as students, interns, citizen researchers, and patient partners.
Ongoing Work:
- Determinants of public trust in government health authorities and officials since COVID-19
- Behavioural factors influencing health care practitioners’ and patients’ use of antivirals to prevent and treat respiratory viruses associated with severe disease
- Reducing Sedentary Behaviour Among Pre- and Early Adolescents (9-14 Years) Living in Urban Environments: A Rapid Evidence Synthesis
- An Umbrella Review of the Effects of Nature-Based Versus Indoor Physical Activity on Psychological Outcomes
- Meta-Research in Rapid Reviews: Optimising Search Strategies to Improve Time-Efficiency and Comprehensiveness
Previous Projects:
- Behavioural factors influencing antiviral stockpiling and distribution
- Access to Dental Care for Socio-Economically Disadvantaged Individuals and Families in Canada
- Effectiveness of the Monovalent XBB.1.5 COVID-19 vaccines
- Effectiveness of isolation on the reduction of the transmission of respiratory infectious diseases (RIDs: i.e., COVID-19, H1N1, SARS, MERS)
- Unintended health and social consequences of isolation and quarantine for respiratory infectious diseases (RIDs: i.e., COVID-19, H1N1, SARS, and MERS)
- Effectiveness of quarantine on the reduction of the transmission of respiratory infectious diseases (RIDs: i.e., COVID-19, H1N1, SARS, and MERS)
- What is the long-term effectiveness of available COVID-19 vaccines for adults, including for variants of concern and over time frames beyond 112 days in those with a primary series and beyond 84 days in those with a primary series and an additional dose?
- Effectiveness of quarantine and isolation for reducing transmission of COVID-19 and other respiratory infections, as well as impacting other individual and social outcomes in non-health care community-based settings
Infographics:
- How well COVID-19 vaccines protect fully vaccinated people after 4-6 months (September 2021)
- Effectiveness of COVID-19 vaccines after 4 to 8 months – all vaccine types and all variants combined (March 2022)
- Effectiveness of COVID-19 vaccines against Omicron (April 2022)
- Effectiveness of Canadian-approved COVID-19 vaccines in preventing hospitalization from the Omicron variant (August 2022)
- Should I still be wearing a mask? (October 2022)
- What is a rapid review (April 2023)